13:29 GMT16 April 2021
Listen Live
    Latin America
    Get short URL
    3300
    Subscribe

    BUENOS AIRES (Sputnik) - The Argentinian government announced on Friday that it will be manufacturing Russia's Sputnik V coronavirus vaccine following a deal signed between the representative of Moscow’s Gamaleya Institute and Argentina's pharmaceutical company Laboratorios Richmond and India's Hetero Labs Limited.

    "A memorandum of understanding was signed between the Management Company of Russian Direct Investment Fund (the representative of Gamaleya) and my client (Laboratorios Richmond), for the purpose of facilitating cooperation between the parties in order to speedily acquire manufacturing of a vaccine against the virus named COVID-19, which is [to be] produced in the Republic of Argentina," the agreement, which was seen by Sputnik, reads.

    Argentina was the first country in Latin America to officially register Sputnik V. The registration by the National Administration of Drugs, Foods and Medical Devices of Argentina (ANMAT) was completed in December 2020.

    The Russian Direct Investment Fund (RDIF) signed a contract with the government of Argentina on December 10 for the supply of 10 million doses of Sputnik V.

    Tags:
    vaccination, Sputnik V, COVID-19, Argentina, Russia
    Community standardsDiscussion